AccessPak for HIV PEP Basic and Insulin Degludec (U-100) Vials
Determining the interaction of AccessPak for HIV PEP Basic and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / tenofovir
Brand name: AccessPak for HIV PEP Basic, Descovy, Truvada
Synonyms: n.a.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Basic-Insulin Degludec (U-200) Prefilled Pens
- AccessPak for HIV PEP Basic-Insulin degludec and liraglutide
- AccessPak for HIV PEP Basic-Insulin degludec and liraglutide Subcutaneous
- AccessPak for HIV PEP Basic-Insulin degludec Subcutaneous
- AccessPak for HIV PEP Basic-Insulin detemir
- AccessPak for HIV PEP Basic-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-AccessPak for HIV PEP Expanded with Kaletra
- Insulin Degludec (U-100) Vials-AccessPak for HIV PEP Expanded with Viracept
- Insulin Degludec (U-100) Vials-Accolate
- Insulin Degludec (U-100) Vials-Accretropin
- Insulin Degludec (U-100) Vials-Accucaine
- Insulin Degludec (U-100) Vials-AccuHist Drops